RFC
RPRX icon

Regions Financial Corp’s Royalty Pharma RPRX Stock Holding History

Regions Financial Corp’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,100
Closed -$371K – 853
2024
Q3 		$371K Hold
13,100
– – ﹤0.01% 646
2024
Q2 		$345K Buy
13,100
+3,100
+31% +$85.9K ﹤0.01% 648
2024
Q1 		$304K Buy
+10,000
New +$295K ﹤0.01% 702

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Regions Financial Corp's RPRX Position: Q4 2024 in Review

Regions Financial Corp sold out of Royalty Pharma (RPRX) in Q4 2024, closing a stake of 13,100 shares — an estimated $371K sold.

Regions Financial Corp first reported a position in RPRX in Q1 2024 and held it in 3 quarters. The position peaked at $371K in Q3 2024. 417 funds tracked by Wall St. Rank hold RPRX as of Q4 2024.

  • Regions Financial Corp reported no remaining Royalty Pharma position as of Q4 2024 after selling out during the quarter.
  • Regions Financial Corp sold 13,100 Royalty Pharma shares in Q4 2024, an estimated $371K.
  • Regions Financial Corp first reported a position in Royalty Pharma in Q1 2024 and held it in 3 quarters.
  • Regions Financial Corp's Royalty Pharma position peaked at $371K in Q3 2024.
  • 417 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2024.

Based on Regions Financial Corp's 13F filing for Q4 2024, filed 14 Feb 2025.